| HOME >> BIOLOGY >> TECHNOLOGY |
Revenues, net 8,187,567 16,558,760 22,575,918 31,363,660
Costs and expenses:
Cost of goods sold 4,912,381 4,036,285 12,786,574 11,544,879
Research and
development 1,040,116 843,858 2,840,227 2,638,413
Marketing, general and
administrative 4,097,401 3,361,582 10,409,662 10,062,093
Total costs and
expenses 10,049,898 8,241,725 26,036,463 24,245,385
(loss) income from
operations (1,862,331) 8,317,035 (3,460,545) 7,118,275
Other (expense) and
income:
Equity in Ocular
Telehealth Management,
LLC (14,013) (25,191) (64,735) (55,889)
Interest income 78,189 54,451 265,277 113,385
Interest expense (17,987) (8,676) (24,276) (23,615)
Total other income 46,189 20,584 176,266 33,881
Net (loss) income before
taxes (1,816,142) 8,337,619 (3,284,279) 7,152,156
Provision for income
taxes 126,480 66,157 126,480 64,914
Net (loss) income $(1,942,622) $8,271,462 $(3,410,759) $7,087,242
Basic net (loss) income
per share $(0.30) $1.39 $(0.53) $1.23
Diluted net (loss) income
per share $(0.30) $1.32 $(0.53) $1.14
Weighted average shares
- basic 6,389,315 5,932,920 6,388,905 5,787,753
Weighted average shares
- diluted 6,389,315 6,251,847 6,388,905 6,238,515
SELECTED BALANCE SHEET DATA:
March 31, June 30,
2
'/>"/>
| SOURCE Escalon Medical Corp. Copyright©2008 PR Newswire. All rights reserved |